She obtained her PhD in Biochemistry and Molecular Biology from the University of Athens. She conducted her post-doctoral studies at the NHRF while she was trained in the use of the model organism C. elegans at the Institute of Molecular Biology and Biotechnology, FORTH in Crete. She focuses on the identification of genetic and environmental factors that govern aging, longevity and age-related diseases with emphasis on the regulation of the proteasome using C. elegans and human primary cells as models. She is a national and international patent holder that resulted in the development of novel anti-aging products that act through activation of the proteasome system (two relative product series are currently in the national and international market). Full CV: http://www.eie.gr/nhrf/institutes/ibrb/cvs/cv-chondrogianni-gr.pdf